Day: August 7, 2020

As Eternal Wallet commits to providing the best rates for currency exchange and largest amount received in overseas remittance, we have decided to integrate the services provided by PaymentWall Inc., an international global payments platform to further improve the usability of Eternal Wallet. By utilizing their service, not only will credit payments be possible, but over 150 electronic cash global deposit channels will be added to Eternal Wallet for the purpose of catering to the wide demands and needs of users. The initial starting date for services is scheduled to be this autumn, October. Eternal Wallet is a digital online-based wallet that is scheduled to start services in late August, and provides users with the world’s most efficient and largest amount of currency received when conducting overseas remittance and/or currency exchange. Features...

SINGAPORE, Aug. 07, 2020 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced its presentation at the BTIG Virtual Biotechnology Conference. Dr Carl Firth, Chief Executive Officer, and Stephen Doyle, Chief Business Officer, are scheduled to participate in a fireside chat on Monday, 10 August, 2020 at 09:00am ET. The conference will be held from 10-11 August 2020.The presentation deck used at the conference will be available in the Investors section of ASLAN’s website at www.aslanpharma.com following the event.EndsMedia and IR contactsAbout ASLAN PharmaceuticalsASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497) is a clinical-stage immunology and oncology focused biopharmaceutical...

HAMILTON, Bermuda, Aug. 07, 2020 (GLOBE NEWSWIRE) — Die Enstar Group Limited („Enstar“) (Nasdaq: ESGR) hat heute bekanntgegeben, dass das Unternehmen Bardividenden auf seine Vorzugsaktien der Serien D und E zahlen wird.Die Dividenden auf die unbefristeten, nicht kumulativen Vorzugsaktien der Serie D der Gesellschaft mit 7,00 % festem zu variablem Zinssatz in Höhe von 0,43750 USD pro Hinterlegungsaktie (von denen jede einen 1/1000-Anteil an einer Vorzugsaktie der Serie D darstellt) sind am Dienstag, 1. September 2020 an am Samstag, 15. August 2020 im Aktienbuch eingetragene Aktionäre zu zahlen.Die Dividenden auf die unbefristeten, nicht kumulativen Vorzugsaktien der Serie E der Gesellschaft mit 7,00 % Zinssatz in Höhe von 0,43750 USD pro Hinterlegungsaktie (von denen jede einen 1/1000-Anteil an einer Vorzugsaktie der Serie E darstellt)...

LONDON, Aug. 07, 2020 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (“Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases, today announced the pricing of its initial public offering in the United States of 8,823,529 American Depositary Shares (“ADSs”) representing 8,823,529 ordinary shares at an initial public offering price of $18.00 per ADS for total gross proceeds of approximately $158.8 million. All ADSs sold in the offering were offered by Freeline. The ADSs are expected to begin trading on The Nasdaq Global Select Market on 7 August 2020 under the ticker symbol “FRLN.”  In addition, Freeline has granted the underwriters a 30-day option to purchase up to...

Wilson Asa rapporterer god og stabil inntjening for andre kvartal 2020 og for første halvår 2020 i en usikker situasjon.For andre kvartal 2020 leverer selskapet EBITDA på MEUR 12,5, som er ned fra MEUR 14,8 for tilsvarende periode i fjor, men en forbedring på MEUR 2,2 fra første kvartal 2020.  Selskapet har i kvartalet inngått avtale med ARKON om tilførsel av 20 skip herav 4 nybygg.EBITDA for årets seks første måneder ble MEUR 22,9, ned fra MEUR 27,0 for første halvår 2019.Hovedpunkt for andre kvartal 2020 (tall i parentes 2Q 2019):Godt resultat i en usikker situasjonNettoinntjening/dag, EUR 3 508 (EUR 3 621)EBITDA på MEUR 12,5 (MEUR 14,8), opp MEUR 2,2 fra første kvartal 2020Inngått avtale med Arkon som tilfører selskapet 20 skip herav 4 nybyggHovedpunkt for første halvår 2020 (tall i parentes første halvår 2019):Bruttoomsetning MEUR...

August 7, 2020: Oslo, Norway, the Board of PGS confirms that it has received a conditional and non-binding offer from TGS to acquire the MultiClient data library of PGS for a cash consideration of $600 million. The offer also includes proposals for the provision of acquisition services by PGS to TGS and the opportunity for TGS to participate in future MultiClient projects undertaken by PGS.PGS Management and the Board of Directors will address the offer.PGS will make an announcement before the offer expires on August 16, 2020.***PGS ASA and its subsidiaries (“PGS” or “the Company”) is a focused marine geophysical company that provides a broad range of seismic and reservoir services, including acquisition, imaging, interpretation, and field evaluation. The Company MultiClient data library is among the largest in the seismic...

MIAMI (July 17, 2020) – Nationally recognized public accounting and advisory firm, MBAF, is proud to announce that Hernando Gomez, principal in the Management Advisory Services Department and principal-in-charge of the Business Valuation division at MBAF, has been re-elected to the Greater Miami Chamber of Commerce (GMCC) Board of Directors for the 2020-2021 term. Gomez will serve as Group Chair of the International Business Growth Committee. In his two prior terms, Gomez served as vice-chair of the Committee. Gomez was officially reappointed to the board during a virtual General Session meeting on June 30. As a board member, Gomez will continue to drive the Chamber’s mission to be “The Voice of Business in South Florida.” The leadership of the GMCC is comprised of a distinguished group of member volunteers representing businesses of all...

Major stocks ended up all high for three consecutive days just this first week of August. The news about reports on the coronavirus vaccine positive development and distribution plan has contributed on the promising outcome in today’s session, alongside with the expected high corporate earnings results. Another passive gain from tech giants which was led by Nasdaq hitting another record high on today’s session after reaching almost 11,000 in its trading price. Gold continuously goes up by the day at above $2000 till investors sees it as the easiest and most reliable way to save their investments. Here are the main movements in the Global Market this Wednesday; Stocks – S&P 500 jumps up with 21.24 points change or 0.64% to 3,327.75.– The Dow Jones Industrial Average climbed with 372.84 points increased or 1.39% to 27,201.31.–...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Aug. 07, 2020 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE:HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that it has entered into a letter of intent dated August 6th, 2020 (the “LOI”), which sets out the basic terms and conditions for the acquisition by the Company of all of the issued and outstanding securities in the capital of Healthview Technologies Inc. (“Healthview”) in exchange for securities of Global Care (the “Transaction”).The Company and Healthview have entered into the LOI, which sets out certain terms and conditions pursuant to which the proposed...

LONDON, Aug. 07, 2020 (GLOBE NEWSWIRE) — OKYO (LSE:OKYO), the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that it is establishing a Scientific Advisory Board which will be led by Dr A. James Khodabakhsh MD. His appointment is effectively immediately, with the remit to bring together a small group of leaders-in-the-field to review and inform the Company’s plans to progress its lead product candidate, Chemerin, to an IND in the indication of dry-eye disease.Dr. James Khodabakhsh specializes in complex surgeries of the eye and is one of the most sought after surgeons in Los Angeles and is the Medical Director at the Beverly Hills Institute of Ophthalmology.He finished his undergraduate degree at New...